Travatan z and Nasal congestion - a phase IV clinical study of FDA data

Summary:

Nasal congestion is reported as a side effect among people who take Travatan z (travoprost), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fosamax, and have Immunodeficiency.

The phase IV clinical study analyzes which people have Nasal congestion when taking Travatan z. It is created by eHealthMe based on reports of 6,080 people who have side effects when taking Travatan z from the FDA, and is updated regularly.

What is Travatan z?

Travatan z has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 6,223 Travatan z users. Check the latest studies of Travatan z.

What is Nasal congestion?

Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels) is found to be associated with 1,763 drugs and 2,490 conditions by eHealthMe. Check the latest studies of Nasal congestion.

On Jul, 09, 2026

6,080 people reported to have side effects when taking Travatan z.
Among them, 15 people (0.25%) have Nasal congestion.

Could Travatan z cause Nasal congestion?

Among these 15 people:

How long have people been on Travatan z when they have Nasal congestion? *

What is the gender of people who have Nasal congestion when taking Travatan z? *

female: 92.86 %
male: 7.14 %

What is the age of people who have Nasal congestion when taking Travatan z? *

What are other drugs people take besides Travatan z? *

What are other side effects people have besides Nasal congestion? *

Oropharyngeal Pain: 6 people, 40.00%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 33.33%
Cough: 5 people, 33.33%
Sinusitis (inflammation of sinus): 5 people, 33.33%
Infusion Site Bruising: 4 people, 26.67%
Sinus Headache (headache caused by sinus infections): 4 people, 26.67%
Localised Infection (infection at the single location): 4 people, 26.67%
Multiple Allergies (allergy to multiple agents): 4 people, 26.67%
Infusion Site Pruritus (severe itching at infusion site): 4 people, 26.67%
Infusion Site Erythema (reddening of the skin at infusion site): 4 people, 26.67%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 4 people, 26.67%
Immunodeficiency: 4 people, 26.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Sleep Disorder: 1 person, 6.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.67%
Intraocular Pressure Test Abnormal: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Dry Eyes (lack of adequate tears): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Travatan z and have Nasal congestion?

- Check whether Nasal congestion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Travatan z:

Travatan z (6,223 reports)

Nasal congestion treatments and more:

Nasal congestion (81,823 reports)

Browse all side effects of Travatan z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasal congestion:

Nasal congestion (1,763 drugs)

Browse all the conditions that are associated with Nasal congestion:

Nasal congestion (2,490 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on travoprost (the active ingredients of Travatan z) and Travatan z (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.